BMY Tshuag: Bristol Cia siab tias $ 10.5 nphom luv luv xyoo no raws li Generics Loom

Bristol Myers Squibb (BMY) tau muab cov lus qhia muag khoom zoo tshaj li qhov kev cia siab rau hnub Friday, thiab BMY Tshuag tau nce txawm tias muaj kev sib tw rau ob ntawm nws cov tshuaj mob qog noj ntshav loj tshaj plaws.




X



Revlimid thiab Abraxane yog ib qho ntawm Bristol cov tshuaj blockbuster, thiab ob qho tib si yog vim poob kev tiv thaiv patent xyoo no. Kev taw qhia rau $ 47 nphom hauv tag nrho kev muag khoom ib xyoos rau lub tuam txhab suav txog kwv yees li $ 10.5 nphom hauv cov nyiaj tau los poob ntawm ob cov tshuaj.

Lub tuam txhab cov nyiaj txiag loj tshaj plaws, Revlimid, xav tias yuav tsim tau $ 9.5 nphom txog $ 10 nphom hauv kev muag khoom xyoo no. Qhov ntawd yuav poob kwv yees li 24% xyoo dhau los. Edward Jones tus kws tshuaj ntsuam Ashtyn Evans hais tias Bristol Myers yuav ua rau Revlimid poob nrog nws cov tshuaj tshiab.

"Peb cia siab tias Bristol yuav txuas ntxiv nqis peev hauv cov khoom lag luam tshiab los tsim cov khoom muag muag," nws hais hauv tsab ntawv tshaj tawm. Evans tuav nws qhov ntsuas ntawm BMY Tshuag.

BMY Tshuag: Cov Nyiaj Tau Los Beat, Muag Teeb

Thaum lub quarter thib plaub, Bristol khwv tau $ 1.83 ib feem, tsis suav nrog qee yam khoom. Cov nyiaj tau los nce 25% xyoo dhau los thiab nce kev kwv yees los ntawm 3 pennies. Kev muag khoom nce 8% mus rau $ 11.99 nphom, tab sis plam qhov kev cia siab rau $ 12.04 billion, raws li FactSet.

Revlimid coj hauv $ 3.33 nphom hauv kev muag khoom, nce 1% siab dua.

Ntau bullishly, cov nyiaj tau los ntawm cov ntshav thinner Eliquis tau nce 18% rau $ 2.67 billion. Bristol Myers kuj tau sau tseg lub zog los ntawm nws cov tshuaj tiv thaiv kab mob oncology, Opdivo thiab Yervoy. Opdivo muag popped 11% rau $ 1.99 billion. Yervoy coj hauv $ 545 lab, nce 16%.

Bristol qhia txog kev loj hlob muaj zog los ntawm Reblozyl, kev kho mob ntshav qab zib los ntawm Bristol thiab Merck (MRK) koom nrog Acceleron Pharma. Reblozyl muag tau dhia 31% rau $ 151 lab.

Rau lub xyoo, Bristol cia siab tias yuav khwv tau $ 7.65- $ 7.95 ib feem, rho tawm qee yam khoom. Qhov nruab nrab ntawm qhov kev taw qhia tau kov BMY cov kws tshuaj ntsuam xyuas cov khoom hu. Kev taw qhia rau $ 47 nphom hauv kev muag khoom tau tshaj qhov kev cia siab rau $ 46.46 billion. Kev muag khoom yuav nce qhov feem pua ​​​​ntawm ib tus lej qis.

Ntawm kev lag luam niaj hnub no, BMY Tshuag nce 1.4% rau 64.99.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Lilly's Covid Antibodies Tsav Tsheb Loj, Tab sis Omicron yuav txwv kev muag khoom

Biogen's Alzheimer's Struggles Mus Ntxiv; Kev muag khoom 'tsawg kawg' xav tau xyoo no

Nrhiav Rau Cov Tom Qab Loj Cov Khoom Lag Luam Loj Tshaj? Pib Nrog 3 Kauj Ruam No

Khiav Cov Khoom Nchuav Ntaus Nrig nrog MarketSmith

Cov Kev Xaiv Ua Lag Luam: Yuav Pib Siv Cov Kev Xaiv, Yuav Ua Li Cas Tswj Cov Kev Nyab Xeeb

Tau qhov twg los: https://www.investors.com/news/technology/bmy-stock-bristol-myers-earnings-q4-2021/?src=A00220&yptr=yahoo